A Systematic Review of Hepatic Artery Chemotherapy after Hepatic Resection of Colorectal Cancer Metastatic to the Liver

Diseases of the Colon and Rectum

Volumn 47, Issue 5, 2004, Pages 739-745

  Nelson, Richard L ^a,b,c   Freels, Sally ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c m/c 957 ^*  (United States)

Author keywords

Colorectal cancer; Hepatic artery chemotherapy; Liver metastases resection; Meta analysis

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; EPIRUBICIN; FLOXURIDINE; FLUOROURACIL; FLUOROURACIL DEOXYRIBOSE; FOLINIC ACID; GAMMA INTERFERON; MITOMYCIN C; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATIC ARTERY; HUMAN; LIVER CANCER; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 2342563092     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-003-0113-7     Document Type: Review

References (12)

1. Bozzetti F, Doci R, Bignami P, Morabito A, Gennari L. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg 1987;205:264-70
2. Lorenz M, Mueller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for live metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998;228:756-62
3. Kemeny MM, Adak S, Gray B, et al. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 2002;20: 1499-505
4. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341: 2039-48
5. Rudroff C, Altendorgf-Hoffmann A, Stangl R, Scheele J. Prospective randomized trial on adjuvant hepatic artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg 1999;384: 243-9
6. Tono T, Hasuike Y, Ohzato H, Takasuka Y, Kikkawa N. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Cancer 2000;88:1549-56
7. Wagman LD: Kemeny MM, Leong L, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990; 8:1885-93
8. Lygidakis NJ, Pothoulakis J, Konstantinidou AE, Spanos H. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study. Anticancer Res 1995; 15:543-50
9. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34
10. Petitti D. Meta-analysis, decision analysis and cost-effectiveness analysis. New York, Oxford University Press, 1994
11. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327: 557-60
12. Freels S. Letter. Stat Med (in press).